Meeting
2013 ASCO Annual Meeting
Safety of asparaginase Erwinia chrysanthemi in a compassionate-use trial: Subanalysis of the adolescent/young adult (AYA) and adult patient (Pt) population.
Authors
Paul V. Plourde
Jazz Pharmaceuticals, Inc., Langhorne, PA
Paul V. Plourde , Sima Jeha , Nobuko Hijiya , Frank G. Keller , Susan R. Rheingold , Zoann Dreyer , Gary V. H. Dahl , Taheri Mercedes , Tim Corn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Leukemia, Myelodysplasia, and Transplantation
Track
Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
Sub Track
Leukemia
Clinical Trial Registration Number
NCT00693602
Citation
J Clin Oncol 31, 2013 (suppl; abstr 7097)
DOI
10.1200/jco.2013.31.15_suppl.7097
Abstract #
7097
Poster Bd #
42A
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
L-asparaginase (L-ASP)-related toxicities with Erwinia L-ASP in a large compassionate-use protocol.
First Author: P. V. Plourde
Poster
2020 ASCO Virtual Scientific Program
A phase II/III study of JZP-458 in patients with acute lymphoblastic leukemia (ALL)/lymphoblastic lymphoma (LBL) who are hypersensitive to E. coli-derived asparaginases.
First Author: Luke Maese
Poster
2023 ASCO Quality Care Symposium
Iron sucrose hypersensitivity reactions in patients within the cancer care setting.
First Author: Madalyn Kai Edmonds
Poster
2023 ASCO Annual Meeting
The Amelia-1 study: A phase 1b/2 trial of evexomostat (SDX-7320) plus fulvestrant and alpelisib in patients with advanced breast cancer at risk for alpelisib-induced hyperglycemia.
First Author: Peter Cornelius